The objective of this presentation is to describe IS strategies and challenges in patients on conventional chemotherapy, targeted therapies, and immunotherapies.
IS strategies and challenges in transplant patients during and after conventional cancer therapy - Rachel Hellemans, University of Antwerp
IS strategies and challenges in transplant patients on immunotherapy and targeted therapies - Naoka Murakami, Washington University
Transplant and Onco-Nephrologist
Cleveland Clinic Foundation
Cleveland, OH
tunu Owoyemi, MBBS, FASN is a board-certified Nephrologist, Transplant and Onco-Nephrologist. She graduated from Oba Okunade Sijuwade College of Medicine, Igbinedion University Okada, Nigeria. Dr. Owoyemi completed her internal medicine residency at Vidant/Medical Center /East Carolina University (ECU), Greenville, North Carolina where she served as Chief Resident of ECU Global health and Underserved Populations Program. She completed her Nephrology training at University of Virginia, Charlottesville Virginia where she served as Chief Fellow and Transplant Nephrology Fellowship at the Thomas E. Starzl Transplantation Institute, UPMC Montefiore. She completed an Onco-Nephrology fellowship at Mayo Clinic Rochester Minnesota in 2020.
Dr. Owoyemi practices Transplant and Onco-Nephrology at the Cleveland Clinic Foundation with a research focus in malignancy and kidney disease.
Prof. Dr., Department of Nephrology
Antwerp University Hospital
Edegem, Belgium
Prof. Dr. Rachel Hellemans, MD, PhD, is a nephrologist and full-time staff member at Antwerp University Hospital and a teacher at the Faculty of Medicine and Health Sciences of the University of Antwerp. She is an active researcher in kidney transplantation and has authored numerous publications in leading international journals. Her clinical and scientific work has a special focus on immunosuppressive management and the prevention and management of post-transplant complications, including malignancies. She serves on the boards of the ERA Descartes Working Group on Kidney Transplantation and the Belgian Transplant Society.
Assistant Professor of Medicine, Transplant Nephrologist
Washington University in St. Louis
St. Louis, USA
Naoka Murakami, MD PhD, is Assistant Professor and a transplant nephrologist at Washington University in St. Louis. Her primary research interest is allograft tolerance and T cell immunobiology. Her research project has been supported by NIH and American Society of Nephrology. Her clinical focus is on the care for kidney transplant recipients with cancer (Transplant Onconephrology), in collaboration with Siteman Cancer Center.
Use the image below to promote this event (right-click to download)